AptarGroup price target lowered to $142 from $158 at BofA

BofA analyst George Staphos lowered the firm’s price target on AptarGroup (ATR) to $142 from $158 and keeps a Neutral rating on the shares. The firm likes Aptar over the long term, given solid positioning in Pharma dispensing. That said, earnings trends could be impacted in the intermediate term by the slowdown in emergency medicine dispensing, litigation, continued weakness in China, and the sluggish profit trend in Beauty, the analyst tells investors in a research note.